Peggy Bourguillon, MD
Family Medicine · Murrells Inlet, SCNPI 1073922753
Payments from drug & device makers
Across 17 payments — averaging $30.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$110
- Merck$96
- AstraZeneca$91
- Amarin Pharma, Inc.$51
- Indivior Inc.$38
- Hologic Sales And Service, LLC$31
- plus $110 from 6 others
Across 1 payment — averaging $125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$125
What the payments were for
- Food & beverage$527100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 2 | $110 |
| Merck | 1 | $96 |
| AstraZeneca | 1 | $91 |
| Amarin Pharma, Inc. | 3 | $51 |
| Indivior Inc. | 2 | $38 |
| Hologic Sales And Service, LLC | 2 | $31 |
| Novartis | 1 | $23 |
| Exact Sciences | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Insmed, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Amgen | 1 | $13 |
How this compares
$527 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DescovyEmtricitabine/Tenofov Alafenam | 11 | $23,398 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $574 |
| Rosuvastatin Calcium | 24 | $333 |
| Metoprolol Succinate | 18 | $255 |
| Gabapentin | 20 | $193 |
| Trazodone Hcl | 32 | $193 |
| Atorvastatin Calcium | 37 | $187 |
| Fluticasone Propionate | 15 | $180 |
| Omeprazole | 16 | $165 |
| Lisinopril | 25 | $160 |
| Levothyroxine Sodium | 25 | $160 |
| Losartan Potassium | 17 | $140 |
| Amlodipine Besylate | 37 | $131 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $127 |
| Simvastatin | 15 | $127 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Murrells Inlet
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.